Metabolomics in the pharmaceutical industry

Drug Discovery Today: Technologies

Volumn 13, Issue , 2015, Pages 25-31

  Reily, Michael D ^a   Tymiak, Adrienne A ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; DRUG INDUSTRY; HUMAN; MASS SPECTROMETRY; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; SCIENCE; DRUG DEVELOPMENT;

DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; METABOLOMICS;

EID: 84937523343     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2015.03.001     Document Type: Review

References (51)

1. J.K. Nicholson, and I.D. Wilson High resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development Progr Drug Res 31 1987 427 479
2. J.C. Lindon, J.K. Nicholson, and J.R. Everett NMR spectroscopy of biofluids Ann Rep NMR Spect 38 1999 1 88
3. D.G. Robertson Metabonomics in toxicology: a review Toxicol Sci 85 2005 809 822
4. D.G. Robertson, and M.D. Reily The current status of metabolomics in drug discovery and development Drug Dev Res 73 2012 535 546
5. D.G. Robertson, M.D. Reily, J.C. Lindon, E. Holmes, and J.K. Nicholson Metabonomic technology as a tool for rapid throughput in vivo toxicity screening J.P. Vanden Heuvel, G.J. Perdew, W.B. Mattes, W.F. Greenlee, Comprehensive toxicology 2002 Elsevier Science BV 583 610
6. M.D. Reily, and J.C. Lindon NMR spectroscopy: principles and instrumentation J.C.L.D.G. Robertson, E. Holmes, J.K. Nicholson, Metabonomics in toxicity assessment 2005 Taylor & Francis 75 104
7. J.C. Lindon, E. Holmes, M.E. Bollard, E.G. Stanley, and J.K. Nicholson Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis Biomarkers 9 2004 1 31
8. J.C. Lindon, J.K. Nicholson, and J.R. Everett NMR spectroscopy of biofluids Annu Rep NMR Spectr 38 1999 1 88
9. D.S. Wishart Advances in metabolite identification Bioanalysis 3 2011 1769 1782
10. G. Theodoridis, H.G. Gika, and I.D. Wilson Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies Mass Spectr Rev 30 2011 884 906
11. W.B. Dunn, D.I. Broadhurst, H.J. Atherton, R. Goodacre, and J.L. Griffin Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy Chem Soc Rev 40 2011 387 426
12. E.J. Want, A. Nordström, H. Morita, and G. Siuzdak From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics J Proteome Res 6 2007 459 468
13. J.C. Lindon, E. Holmes, and J.K. Nicholson Metabonomics techniques and applications to pharmaceutical research & development Pharma Res 23 2006 1075 1088
14. O. Fiehn Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks Comp Funct Genomics 2 2001 155 168
15. M.D. Reily, P. Shipkova, and S. Hnatyshyn LC-MS in endogenous metabolite profiling and small molecule biomarker discovery M.S. Lee, M. Zhu, Mass spectrometry in drug metabolism and disposition: basic principles and applications 2011 John Wiley
16. B.M. Warrack, S. Hnatyshyn, K.H. Ott, M.D. Reily, M. Sanders, H. Zhang, and et al. Normalization strategies for metabonomic analysis of urine samples J Chromatogr B: Anal Technol Biomed Life Sci 877 5-6 2009 547 552
17. J. van der Greef, R. van der Heijden, and E.R. Verheij The role of mass spectrometry in systems biology: data processing and identification strategies in metabolomics Adv Mass Spectr 16 2004 145 165
18. O. Fiehn Combining genomics, metabolome analysis, and biochemical modeling to understand metabolic networks Comp Func Genom 2 2001 155 168
19. S. Hnatyshyn, and P. Shipkova Automated and unbiased analysis of LC-MS metabolomic data Bioanalysis 4 5 2012 541 554
20. J.K. Nicholson, M.J. Buckingham, and P.J. Sadler High resolution proton NMR studies of vertebrate blood and plasma Biochem J 211 3 1983 605 615
21. J.R. Bales, D.P. Higham, I. Howe, J.K. Nicholson, and P.J. Sadler Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine Clin Chem 30 3 1984 426 432
22. J.K. Nicholson, J. Connelly, J.C. Lindon, and E. Holmes Metabonomics: a platform for studying drug toxicity and gene function. Review 86 refs Drug Discov 1 2 2002 153 161 Nature Reviews
23. R.A. Chylla, K. Hu, J.J. Ellinger, and J.L. Markley Deconvolution of two-dimensional NMR spectra by fast maximum likelihood reconstruction: application to quantitative metabolomics Anal Chem 83 12 2011 4871 4880
24. M.D. Reily, and J.C. Lindon NMR spectroscopy: principles and instrumentation J.C.L.D.G. Robertson, E. Holmes, J.K. Nicholson, Metabonomics in safety assessment 2005 Taylor & Francis
25. H.C. Keun, T.M.D. Ebbels, H. Antti, M.E. Bollard, O. Beckonert, G. Schlotterbeck, and et al. Analytical reproducibility in 1H NMR-based metabonomic urinalysis Chem Res Toxicol 15 11 2002 1380 1386
26. N. Shanks, R. Greek, and J. Greek Are animal models predictive for humans? Philos Ethics Hum Med 4 1 2009
27. D.G. Robertson, and U. Frevert Metabolomics in drug discovery and development Clin Pharmacol Therap 94 5 2013 559 561
28. L.C. Robosky, D.F. Wells, L.A. Egnash, M.L. Manning, M.D. Reily, and D.G. Robertson Communication regarding metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats Toxicol Sci 91 1 2006 p309
29. L.C. Robosky, D.F. Wells, L.A. Egnash, M.L. Manning, M.D. Reily, and D.G. Robertson Metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats Toxicol Sci 87 1 2005 277 284
30. T.J. Wang, D. Ngo, N. Psychogios, A. Dejam, M.G. Larson, R.S. Vasan, and et al. 2-Aminoadipic acid is a biomarker for diabetes risk J Clin Invest 123 10 2013 4309 4317
31. C.B. Newgard, J. An, J.R. Bain, M.J. Muehlbauer, R.D. Stevens, L.F. Lien, and et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance Cell Metab 9 4 2009 311 326
32. J.D. Rabinowitz, J.G. Purdy, L. Vastag, T. Shenk, and E. Koyuncu Metabolomics in drug target discovery Cold Spring Harbor Symp Quant Biol 76 2011 235 246
33. J.D. Clarke, P. Novak, A.D. Lake, P. Shipkova, N. Aranibar, D. Robertson, and et al. Characterization of hepatocellular carcinoma-related genes and metabolites in human nonalcoholic fatty liver disease Toxicol Sci 126 1 2012 p429
34. D.G. Robertson Metabonomics in toxicology: a review Toxicol Sci 85 2 2005 809 822
35. D.G. Robertson, M.D. Reily, R.E. Sigler, D.F. Wells, D.A. Paterson, and T.K. Braden Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants Toxicol Sci 57 2 2000 326 337
36. J.C. Lindon, E. Holmes, and J.K. Nicholson Metabonomics: systems biology in pharmaceutical research and development Curr Opin Mol Ther 6 3 2004 265 272
37. J.C. Lindon, H.C. Keun, T.M.D. Ebbels, J.M.T. Pearce, E. Holmes, and J.K. Nicholson The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements Pharmacogenomics 6 7 2005 691 699
38. N. Aranibar, J.D. Vassallo, J. Rathmacher, S. Stryker, Y. Zhang, J. Dai, and et al. Identification of 1- and 3-methylhistidine as biomarkers of skeletal muscle toxicity by nuclear magnetic resonance-based metabolic profiling Anal Biochem 410 1 2010 84 91
39. V.R. Young, L.N. Haverberg, C. Bilmazes, and H.N. Munro Potential use of 3-methylhistidine excretion as an index of progressive reduction in muscle protein catabolism during starvation Metabolism 23 2 1973 1429 1436
40. N. Aranibar, V. Bhaskaran, K.H. Ott, J. Vassallo, D. Nelson, L. Lecureux, and et al. Modulation of ascorbic acid metabolism by cytochrome P450 induction revealed by metabonomics and transcriptional profiling Magn Res Chem 47 Suppl. 1 2009 S12 S19
41. L. Tomlinson, M.A. Tirmenstein, E.B. Janovitz, N. Aranibar, K.H. Ott, J.C. Kozlosky, and et al. Cannabinoid receptor antagonist-induced striated muscle toxicity and ethylmalonic-adipic aciduria in beagle dogs Toxicol Sci 129 2 2012 268 279
42. P. Shipkova, J.D. Vassallo, N. Aranibar, S. Hnatyshyn, H. Zhang, T.A. Clayton, and et al. Urinary metabolites of 2-bromoethanamine identified by stable isotope labelling: Evidence for carbamoylation and glutathione conjugation Xenobiotica 41 2 2011 144 154
43. J.K. Nicholson Global systems biology, personalized medicine and molecular epidemiology Mol Syst Biol 2 2006
44. T.A. Clayton, J.C. Lindon, O. Cloarec, H. Antti, C. Charuel, G. Hanton, and et al. Pharmaco-metabonomic phenotyping and personalized drug treatment Nature 440 7087 2006 1073 1077
45. J.H. Winnike, Z. Li, F.A. Wright, J.M. MacDonald, T.M. O'Connell, and P.B. Watkins Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans Clin Pharmacol Therap 88 1 2010 45 51
46. J. Jackson, R. Townsend, M. Reily, H. Soares, and S. Averbuch Scientific domains of personalized medicine J. Hawana, D. Runkle, Personalized medicine: prescriptions and prospects 2011 The Food and Drug Law Institute 1 16
47. N. Aranibar, and M.D. Reily NMR methods for metabolomics of mammalian cell culture bioreactors R. Portner, Methods in molecular biology 2014 223 236
48. S.A. Bradley, A. Ouyang, J. Purdie, T.A. Smitka, T. Wang, and A. Kaerner Fermentanomics: monitoring mammalian cell cultures with NMR spectroscopy J Am Chem Soc 132 28 2010 9531 9533
49. W.P.K. Chong, L.T. Goh, S.G. Reddy, F.N.K. Yusufi, D.Y. Lee, N.S.C. Wong, and et al. Metabolomics profiling of extracellular metabolites in recombinant Chinese Hamster Ovary fed-batch culture Rapid Commun Mass Spectr 23 23 2009 3763 3771
50. N. Aranibar, M. Borys, N.A. Mackin, V. Ly, N. Abu-Absi, S. Abu-Absi, and et al. NMR-based metabolomics of mammalian cell and tissue cultures J Biomol NMR 49 3-4 2011 195 206
51. J.L. Wagstaff R.J. Masterton, J.F. Povey, C.M. Smales, and M.J. Howard 1H NMR spectroscopy profiling of metabolic reprogramming of Chinese hamster ovary cells upon a temperature shift during culture PLoS ONE 8 10 2013